I am fascinated about how genomic variation leads to disease & how we can use this knowledge to improve treatment.
The reasons for this are unclear but suggests for such patients this would be a good first approach.
Pls read and RT. If you have questions DM me.
4/4
The reasons for this are unclear but suggests for such patients this would be a good first approach.
Pls read and RT. If you have questions DM me.
4/4
If you don't have trio data don't worry, we show that 81% of variants in high CCRs are also pathogenic.
3/4
If you don't have trio data don't worry, we show that 81% of variants in high CCRs are also pathogenic.
3/4
We show that >91% of de novo variants in highly Constrained Coding Regions (CCR) are clinically diagnosed in #raredisease patients as pathogenic.
This corresponds to around 9% of the cohort.
Question: Why is that important?
2/4
We show that >91% of de novo variants in highly Constrained Coding Regions (CCR) are clinically diagnosed in #raredisease patients as pathogenic.
This corresponds to around 9% of the cohort.
Question: Why is that important?
2/4
If you have any ideas pls share and RT 🙏
2/2
If you have any ideas pls share and RT 🙏
2/2